Ryan Merrell

1.7k citations

35 papers · 261 indexed · h-index 10

Impact in

Genetics top 10%
- Glioma Diagnosis and Treatment
Cancer Research
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Genetics 28
- Glioma Diagnosis and Treatment 28
Cancer Research 8
- Cancer, Hypoxia, and Metabolism 7

Co-authors: David A. Reardon (15 shared papers)Martin J. van den Bent (15 shared papers)Lisa Roberts-Rapp (14 shared papers)Erica Gomez (13 shared papers)Andrew B. Lassman (16 shared papers)Hui Gan (15 shared papers)Priya Kumthekar (14 shared papers)Kyle D. Holen (12 shared papers)
Journals: Journal of Clinical Oncology (10 papers)Neuro-Oncology (9 papers)Annals of Oncology (2 papers)Cancer (1 paper)Scientific Reports (1 paper)
Partner nations: United States Netherlands Australia

In The Last Decade

Ryan Merrell

34 papers receiving 258 citations

Peers

Countries citing papers authored by Ryan Merrell

Since Specialization

Citations

This map shows the geographic impact of Ryan Merrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Merrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Merrell more than expected).

Fields of papers citing papers by Ryan Merrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Merrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Merrell. The network helps show where Ryan Merrell may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan Merrell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan Merrell Line = papers co-authored together Ryan Merrell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma Neuro-Oncology ·Hui Gan, David A. Reardon, Andrew B. Lassman, Ryan Merrell, Martin J. van den Bent, Nicholas Butowski, Zarnie Lwin, Helen Wheeler, Lisa Fichtel, Andrew M. Scott, Erica Gomez, JuDee Fischer, Helen Mandich, Hao Xiong, Ho‐Jin Lee, Wijith Munasinghe, Lisa Roberts-Rapp, Peter Ansell, Kyle D. Holen, Priya Kumthekar	2017	57
2	NRG/RTOG 1122: A phase 2, double‐blinded, placebo‐controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma Cancer ·Eudocia Q. Lee, Peixin Zhang, Patrick Y. Wen, Elizabeth R. Gerstner, David A. Reardon, Kenneth Aldape, John DeGroot, Edward Pan, Jeffrey J. Raizer, Lyndon J. Kim, Steven J. Chmura, H. Ian Robins, Jennifer Connelly, James Battiste, John L. Villano, Naveed Wagle, Ryan Merrell, Merideth M Wendland, Minesh P. Mehta	2020	28
3	Multifocal and Multicentric Glioblastoma with Leptomeningeal Gliomatosis: A Case Report and Review of the Literature Case Reports in Medicine ·Sophia F. Shakur, Esther N. Bit‐Ivan, William Watkin, Ryan Merrell, Hamad Farhat	2013	21
4	Phase I study of ABT-414 mono- or combination therapy with temozolomide (TMZ) in recurrent glioblastoma (GBM). Journal of Clinical Oncology ·Hui Gan, Kyriakos P. Papadopoulos, Lisa Fichtel, Andrew B. Lassman, Ryan Merrell, Martin J. van den Bent, Priya Kumthekar, Andrew M. Scott, Michelle Pedersen, Erica Gomez, JuDee Fischer, William Ames, Hao Xiong, Ho-Jin Lee, Wijith Munasinghe, Lisa Roberts-Rapp, Peter Ansell, Kyle D. Holen, Rose Lai, David A. Reardon	2015	17
5	A phase 1 study evaluating ABT-414 in combination with temozolomide (TMZ) for subjects with recurrent or unresectable glioblastoma (GBM). Journal of Clinical Oncology ·Hui Gan, Lisa Fichtel, Andrew B. Lassman, Ryan Merrell, Martin J. van den Bent, Priya Kumthekar, Andrew M. Scott, Michelle Pedersen, Erica Gomez, JuDee Fischer, William Ames, Hao Xiong, Matthew W. Dudley, Wijith Munasinghe, Lisa Roberts-Rapp, Peter Ansell, Kyle D. Holen, David A. Reardon	2014	16
6	Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis Scientific Reports ·Laura Dresser, Carlen Yuen, Andrew Wilmington, Matthew T. Walker, Tilley Jenkins Vogel, Ryan Merrell, David Kamson	2020	15
7	Anaplastic Glioma Current Treatment Options in Neurology ·Nina A. Paleologos, Ryan Merrell	2012	10
8	Brain Tumors Disease-a-Month ·Ryan Merrell	2012	9
9	Twofold improved tumor-to-brain contrast using a novel T1 relaxation-enhanced steady-state (T ₁ RESS) MRI technique Science Advances ·Robert R. Edelman, Nondas Leloudas, Jianing Pang, Julian E. Bailes, Ryan Merrell, Ioannis Koktzoglou	2020	9
10	Brain Tumor Trials Collaborative Bayesian Adaptive Randomized Phase II trial of bevacizumab plus vorinostat versus bevacizumab alone in adults with recurrent glioblastoma (BTTC-1102). Journal of Clinical Oncology ·Vinay K. Puduvalli, Jing Wu, Ying Yuan, Terri S. Armstrong, Morris D. Groves, Jeffrey J. Raizer, Pierre Giglio, Howard Colman, David M. Peereboom, Tobias Walbert, Nicholas G. Avgeropoulos, Fábio M. Iwamoto, Marc C. Chamberlain, Nina A. Paleologos, Karen Fink, Ryan Merrell, W.K. Alfred Yung, Mark R. Gilbert	2015	9
11	BRAF inhibition with concomitant tumor treating fields for a multiply progressive pleomorphic xanthoastrocytoma CNS Oncology ·Rimas V. Lukas, Ryan Merrell	2018	8
12	Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, as monotherapy in epidermal growth factor receptor (EGFR) amplified, recurrent glioblastoma (GBM). Journal of Clinical Oncology ·Martin J. van den Bent, Hui Gan, Andrew B. Lassman, Priya Kumthekar, Ryan Merrell, Nicholas Butowski, Zarnie Lwin, Tom Mikkelsen, Burt Nabors, Kyriakos P. Papadopoulos, Marta Penas‐Prado, John Simes, Helen Wheeler, Erica Gomez, Ho‐Jin Lee, Lisa Roberts-Rapp, Hao Xiong, Earle Bain, Kyle D. Holen, David A. Reardon	2016	8
13	Efficacy analysis of ABT-414 with or without temozolomide (TMZ) in patients (pts) with EGFR-amplified, recurrent glioblastoma (rGBM) from a multicenter, international phase I clinical trial. Journal of Clinical Oncology ·Andrew B. Lassman, Martin J. van den Bent, Hui Gan, David A. Reardon, Priya Kumthekar, Nicholas Butowski, Zarnie Lwin, Tom Mikkelsen, Burt Nabors, Kyriakos P. Papadopoulos, Marta Peñas-Prado, John Simes, Helen Wheeler, Erica Gomez, Ho‐Jin Lee, Lisa Roberts-Rapp, Hao Xiong, Earle Bain, David Maag, Ryan Merrell	2017	6
14	ET-19 * A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM) Neuro-Oncology ·Hui Gan, Lisa Fichtel, Andrew B. Lassman, Ryan Merrell, Martin J. van den Bent, Priya Kumthekar, Andrew M. Scott, Michelle Pedersen, Erica Gomez, JuDee Fischer, William Ames, Hao Xiong, M. Dudley, Wijith Munasinghe, Lisa Roberts-Rapp, Peter Ansell, Kyle D. Holen, David A. Reardon	2014	6
15	A Phase 1 Study Evaluating ABT-414 with Temozolomide (TMZ) or Concurrent Radiotherapy (RT) and TMZ in Glioblastoma (GBM) (S43.006) Neurology ·Andrew B. Lassman, Hui Gan, Lisa Fichtel, Ryan Merrell, Martin J. van den Bent, Priya Kumthekar, Andrew M. Scott, Michelle Pedersen, Erica Gomez, JuDee Fischer, William Ames, Hao Xiong, Ho‐Jin Lee, Wijith Munasinghe, Lisa Roberts-Rapp, Peter Ansell, Kyle D. Holen, David A. Reardon	2015	5
16	A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma Neuro-Oncology Advances ·Riley K. Driscoll, Séan Lyne, David J. Voce, Stefania Maraka, Vinai Gondi, Steven J. Chmura, Karan Dixit, Priya Kumthekar, Theodore Karrison, Peter Pytel, John M. Collins, Roger Stupp, Ryan Merrell, Rimas V. Lukas, Bakhtiar Yamini	2024	4
17	Effect of therapeutic pressure on stability of EGFR amplification in glioblastoma. Journal of Clinical Oncology ·Manmeet S. Ahluwalia, Cara Dimino, Mahesh Mansukhani, Vundavalli V. Murty, Peter Canoll, Yoshitaka Narita, Yoshihiro Muragaki, Hui Gan, Ryan Merrell, Martin J. van den Bent, Zheng Zha, Lisa Roberts-Rapp, Fang Jiang, M E Guseva, Earle Bain, Christopher Ocampo, Peter Ansell, Andrew B. Lassman	2018	4
18	Intracranial, intra-axial metastatic giant cell tumor of bone: Case report and review of literature Clinical Neurology and Neurosurgery ·Ricky H. Wong, Beenu Thakral, William Watkin, Ryan Merrell, Andrew K. Wong, Hamad Farhat	2013	3
19	CTNI-47. INTERIM RESULTS OF NCT03011671: A MULTI-INSTITUTIONAL PHASE I STUDY OF ACETAZOLAMIDE WITH TEMOZOLOMIDE IN ADULTS WITH NEWLY DIAGNOSED MGMT-METHYLATED MALIGNANT GLIOMA Neuro-Oncology ·Bakhtiar Yamini, Séan Lyne, Riley K. Driscoll, Giovanna M. Bernal, Longtao Wu, M. Kelly Nicholas, S.J. Chmura, John M. Collins, Deric Park, Peter Pytel, Theodore Karrison, Roger Stupp, Sean Grimm, Vinai Gondi, Ryan Merrell, Rimas V. Lukas	2021	3
20	Randomized phase IIb trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas. Journal of Clinical Oncology ·Ryan Merrell, Patrick Y. Wen, Deborah Forst, Jessica Schulte, Yazmín Odia, Daniela A. Bota, Francisco Díaz‐Mitoma, David E. Anderson, Andrew B. Lassman, Fábio M. Iwamoto	2024	2

About Ryan Merrell

Ryan Merrell is a scholar working on Genetics, Cancer Research, Oncology, Transplantation and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 261 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (28 papers), Cancer Treatment and Pharmacology (10 papers), Brain Metastases and Treatment (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Meningioma and schwannoma management (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Advanced MRI Techniques and Applications (2 papers). The work is most often cited by research in Genetics (146 citations), Cancer Research (51 citations), Oncology (89 citations), Radiology, Nuclear Medicine and Imaging (60 citations) and Neurology (33 citations). Ryan Merrell has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include David A. Reardon, Martin J. van den Bent, Lisa Roberts-Rapp, Erica Gomez, Andrew B. Lassman, Hui Gan, Priya Kumthekar, Kyle D. Holen, Peter Ansell and Nina A. Paleologos. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Annals of Oncology, Cancer and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact